In addition, studies by Chorzalska et al. suggest that the low expression of Abi1 may associate with drug resistance of Bcr-Abl-positive leukemic cells, whereas Juskevicius et al. reported that relapsing diffuse large B cell lymphoma (DLBCL) more commonly displayed gains of a cluster of genes including Abi1 [32, 33]. Here, ABI1 is linked to diffuse large B-cell lymphoma.